Fund Holdings — BVF INC/IL

Total Portfolio Value
$3.91B
Total Bought
$680.79M
Total Sold
$203.27M
Net Transaction
+$477.52M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
REVOLUTION MEDICINES INC(RVMD)2,856,7822,965,160+108,378277,822555,31514.20%+277,493
XOMA ROYALTY CORPORATION2,590,3037,593,303+5,003,00081,258322,7158.25%+241,458
GH RESEARCH PLC(GHRS)8,650,1588,650,1580121,621232,5165.95%+110,895
ALKERMES PLC(ALKS)2,000,0002,154,704+154,70470,720112,8962.89%+42,176
MONTE ROSA THERAPEUTICS INC(GLUE)4,460,8864,460,886073,382107,9532.76%+34,572
Q32 BIO INC(FIXX)02,350,000+2,350,000029,9390.77%+29,939
XENCOR INC(XNCR)7,133,7207,133,720086,033114,8532.94%+28,820
ABSCI CORPORATION02,361,674+2,361,674027,3720.70%+27,372
KURA ONCOLOGY INC(KURA)8,445,7698,445,769068,66492,6502.37%+23,986
CULLINAN THERAPEUTICS INC(CGEM)5,750,6835,750,683081,717104,7202.68%+23,003
SAGIMET BIOSCIENCES INC(SGMT)02,500,000+2,500,000019,3250.49%+19,325
AVALO THERAPEUTICS INC(AVTX)1,632,8452,075,545+442,70024,37838,3560.98%+13,978
STRUCTURE THERAPEUTICS INC3,459,3583,366,823-92,535166,741180,6974.62%+13,956
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)16,001,28416,001,2840298,264311,5457.97%+13,281
ANTERIS TECHNOLOGIES GLOBAL(AVR)3,000,0003,000,000016,65029,5500.76%+12,900
IMMUNIC INC(IMUX)0765,295+765,295011,7630.30%+11,763
4D MOLECULAR THERAPEUTICS IN2,879,2892,879,289026,80638,2950.98%+11,488
SUTRO BIOPHARMA INC(STRO)1,251,7881,251,788031,18241,5591.06%+10,377
ONKURE THERAPEUTICS INC(OKUR)1,978,9723,235,778+1,256,8068,19314,7550.38%+6,562
ELEDON PHARMACEUTICALS INC(ELDN)6,293,2826,293,282019,38324,7960.63%+5,412
RESEARCH ALLIANCE CORP III0500,000+500,00005,3500.14%+5,350
ENTERA BIO LTD(ENTX)02,425,000+2,425,00004,2920.11%+4,292
DISC MEDICINE INC(IRON)1,272,3121,153,612-118,70081,35284,3752.16%+3,024
IMMUNOCORE HLDGS PLC(IMCR)1,294,4631,294,463039,02841,0991.05%+2,071
ZYMEWORKS INC(ZYME)3,734,1423,649,142-85,00093,50395,3892.44%+1,886
ANNEXON INC(ANNX)8,698,1738,698,173048,18849,6671.27%+1,479
X4 PHARMACEUTICALS INC(XFOR)2,233,7422,233,74209,22510,4320.27%+1,206
IMAGENEBIO INC(IMA)1,110,0021,110,00205,5506,5490.17%+999
FOGHORN THERAPEUTICS INC(FHTX)5,842,0005,842,000027,92528,5090.73%+584
STOKE THERAPEUTICS INC(STOK)2,547,5572,547,557082,94883,3562.13%+408
ENGENE THERAPEUTICS0945,402+945,40202740.01%+274
TSCAN THERAPEUTICS INC(TCRX)5,564,2905,564,29005,6205,4540.14%-166
MOLECULAR PARTNERS AG(MOLN)1,353,9681,353,96805,3625,1450.13%-217
TENAX THERAPEUTICS INC(TENX)339,549339,54905,4294,9400.13%-489
INVIVYD INC(IVVD)19,525,00028,165,000+8,640,00025,38324,5710.63%-811
CRESCENT BIOPHARMA INC.(CBIO)2,748,7632,748,763050,49549,4781.27%-1,017
INVENTIVA SA(IVA)686,040686,04003,8082,5930.07%-1,214
ENGENE HOLDINGS INC
*W EXP 10/31/202
945,4020-945,4022,4860—-2,486
AC IMMUNE SA(ACIU)19,822,43619,822,436054,51247,1771.21%-7,334
IMMUNIC INC(IMUX)7,652,9720-7,652,9728,4950—-8,495
OLEMA PHARMACEUTICALS INC(OLMA)5,295,8935,295,893078,96266,2521.69%-12,710
KYMERA THERAPEUTICS INC(KYMR)5,502,7103,872,052-1,630,658458,321444,00811.35%-14,313
PALVELLA THERAPEUTICS INC NE(PVLA)960,989672,789-288,200119,787102,8162.63%-16,972
NEKTAR THERAPEUTICS(NKTR)2,559,5952,391,075-168,520184,163166,9214.27%-17,242
MIRUM PHARMACEUTICALS INC(MIRM)1,584,7271,056,027-528,700146,397123,6293.16%-22,768
TYRA BIOSCIENCES INC(TYRA)1,976,1961,476,196-500,00075,68847,1501.21%-28,539
SEPTERNA INC(SEPN)1,353,2490-1,353,24932,5190—-32,519
COMPASS THERAPEUTICS INC(CMPX)7,764,8420-7,764,84241,0760—-41,076
Page 1 of 1
BVF INC/IL — 13F Holdings — Q2 2026 | TickerTrail